郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Oligo-3-hydroxybutyrates as potential carriers for drug delivery.

期刊：Biomaterials发表年份：2004作者：Valeria Piddubnyak; Piotr Kurcok; Andrzej Matuszowicz; Magdalena Głowala; Anna Fiszer-Kierzkowska; Zbigniew Jedliński; Maria Juzwa; Zdzisław Krawczyk
阅读更多 →

药效评价Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.

期刊：Nature medicine发表年份：2004作者：Weijia Kong; Jing Wei; Parveen Abidi; Meihong Lin; Satoru Inaba; Cong Li; Yanling Wang; Zizheng Wang; Shuyi Si; Huaining Pan; Shukui Wang; Jingdan Wu; Yue Wang; Zhuorong Li; Jingwen Liu; Jian-Dong Jiang
阅读更多 →

药效评价P-glycoprotein retains function when reconstituted into a sphingolipid- and cholesterol-rich environment.

期刊：Journal of lipid research发表年份：2004作者：Szabolcs Modok; Catherine Heyward; Richard Callaghan
阅读更多 →

药效评价Characterization of promoter elements involved in the down-regulation of topoisomerase IIalpha expression in a drug-resistant cell line.

期刊：Gene发表年份：2004作者：Deepa Saxena; Gary K Yiu; Xiaoyan Ni; Kuan-Chun Huang; Roberto Mantovani; Alain G Jacquemin-Sablon; Shu-Wing Ng
阅读更多 →